MedPath

Steroid Versus Glucose Injection in Frozen Shoulder

Phase 2
Conditions
Health Condition 1: M750- Adhesive capsulitis of shoulder
Registration Number
CTRI/2023/04/051414
Lead Sponsor
AIIMS Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients aged between 25-60 years of both genders.

2. Patients with AC with duration of symptoms more than 3 months.

3. Patients who have a normative radiograph finding of the affected shoulder.

4. Moderate to severe pain (VAS > 50).

5. Limitation of both active and passive movements of the shoulder joint of 25% or more in 2 or more directions (abduction,flexion,external rotation,internal rotation).

Exclusion Criteria

1. Patients with secondary Adhesive Capsulitis (secondary to inflammatory joint disease, structural/functional limitations in the shoulder joint from any other pre-existing musculoskeletal pathology or neurologic disorder).

2. Patients who have previously undergone any Intra Articular injection/invasive procedure/surgery in the shoulder joints.

3. uncontrolled DM.

4. Poor cognitive status, who are unable to follow exercise program.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale (VAS) for Pain intensityTimepoint: At baseline (V0), 3 weeks (V1) after injection, 6 weeks (V2) <br/ ><br> after injection and 12 weeks (V3) after injection
Secondary Outcome Measures
NameTimeMethod
Shoulder Pain and Disability Index (SPADI) questionnaire, Active and Passive range of motion of the Shoulder using universal goniometer, WHO-QOL BREF questionnaire for assessment of change in Quality of life.Timepoint: at baseline, at 3 weeks, at 6 weeks and at 12 weeks after the intervention.
© Copyright 2025. All Rights Reserved by MedPath